JUBILANT INGREVIA LIMITED (JUBLINGREA) financials

JUBILANT INGREVIA LIMITED (JUBLINGREA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceuti…

  • Market Cap: ₹10,050Cr.
  • Current Price: ₹631
  • Stock P/E: 29.1
  • ROE: 11.0%
  • ROCE: 12.4%
  • Book Value: ₹166
  • Dividend Yield: 0.79%
  • 52W High / Low: ₹795/535

In Jun 2026, JUBILANT INGREVIA LIMITED (JUBLINGREA) reported sales ₹1,253 Cr and net profit ₹126 Cr.

Annual TTM: sales ₹4,418 Cr, net profit ₹335 Cr.

Shareholding: Promoters 45.22% (Sep 2026), FIIs 6.93% (Sep 2026), DIIs 25.18% (Sep 2026), Government 0.02% (Sep 2026), Public 21.69% (Sep 2026).

JUBLINGREA quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,0059959729731,0541,0181,0931,253
Expenses8788648448529539069561,039
Operating Profit128131128121101112138214
OPM %13%13%13%12%10%11%13%17%
Other Income927361111204611
Interest1715161514151314
Depreciation3737373839424341
Profit before tax82106111795975128170
Tax %27%24%19%26%26%21%18%26%
Net Profit608190594460105126
EPS in Rs3.785.065.643.702.763.756.617.92
Raw PDF————————
JUBLINGREA profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales06694,8604,5603,9873,9414,1384,418
Expenses05724,0394,0643,5783,4663,6653,854
Operating Profit-097821496409475473565
OPM %—14%17%11%10%12%11%13%
Other Income0-10213029818687
Interest09463866655756
Depreciation021120120133147161163
Profit before tax-056675368239343342432
Tax %0%31%33%31%32%23%22%—
Net Profit-039452253162263268335
EPS in Rs-3.402.4228.3915.9110.2016.5416.8221.04
Dividend Payout %0%14%18%31%49%30%30%—
JUBLINGREA balance sheet (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.05161616161616
Reserves-01,5601,9672,1432,2312,4252,624
Borrowings0782469645870825747
Other Liabilities08821,2001,2551,2231,2551,337
Total Liabilities03,2403,6524,0584,3404,5214,723
Fixed Assets01,7271,7281,7752,2922,3352,366
CWIP065167477181197139
Investments0135139172297310327
Other Assets01,3131,6191,6351,5711,6791,892
Total Assets03,2403,6524,0584,3404,5214,723
JUBLINGREA cash flows (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0104587446394441462
Cash from Investing Activity032-221-475-464-211-108
Cash from Financing Activity0-70-4103364-208-230
Net Cash Flow066-443-622124
Free Cash Flow077365355239335
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit0%119%85%104%104%108%116%
JUBLINGREA shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters51.47%51.47%45.22%45.22%45.22%45.22%45.22%45.22%
FIIs6.89%7.12%6.96%5.96%6.15%6.49%6.49%6.93%
DIIs15.99%15.91%21.81%23.04%24.00%24.76%24.98%25.18%
Government0.00%0.00%0.00%0.02%0.02%0.02%0.02%0.02%
Public24.90%24.76%25.30%24.94%23.80%22.53%22.30%21.69%
Others0.74%0.73%0.72%0.82%0.80%0.98%0.98%0.96%
No. of Shareholders1,24,8301,20,4061,23,7481,25,7491,17,5291,12,6961,10,9491,09,650
JUBLINGREA key ratios
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days—2624440525361
Inventory Days—49097127132141116
Days Payable—649101117129139139
Cash Conversion Cycle—1034050555538
Working Capital Days—1793223121810
ROCE %—7%30%16%11%13%12%
JUBLINGREAUpdated 18 Oct 2026, 5:40

Jubilant Ingrevia Limited

Market Cap

₹10,050Cr.

Current Price

₹631

High / Low

₹795/535

Stock P/E

29.1

ROE11.0%
ROCE12.4%
Book Value₹166
Face Value₹1.00
Dividend Yield0.79%

About

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days—2624440525361
Inventory Days—49097127132141116
Days Payable—649101117129139139
Cash Conversion Cycle—1034050555538
Working Capital Days—1793223121810
ROCE %—7%30%16%11%13%12%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of JUBILANT INGREVIA LIMITED (JUBLINGREA)?

The reported market capitalisation for JUBILANT INGREVIA LIMITED (JUBLINGREA) is ₹10,050Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of JUBLINGREA?

The current price shown for JUBILANT INGREVIA LIMITED (JUBLINGREA) on Fincrux is ₹631 with a 52-week high/low of ₹795/535.

What is the P/E ratio of JUBILANT INGREVIA LIMITED (JUBLINGREA)?

The stock P/E for JUBILANT INGREVIA LIMITED (JUBLINGREA) is 29.1 on Fincrux, with ROE at 11.0% and ROCE at 12.4%.

What were JUBLINGREA latest quarterly results?

For Jun 2026, JUBILANT INGREVIA LIMITED (JUBLINGREA) reported sales ₹1,253 Cr and net profit ₹126 Cr (figures in ₹ crore unless noted).

What are JUBLINGREA annual sales and net profit?

For TTM, JUBILANT INGREVIA LIMITED (JUBLINGREA) shows sales of ₹4,418 Cr and net profit of ₹335 Cr on the Fincrux profit & loss statement.

Who owns JUBILANT INGREVIA LIMITED (JUBLINGREA)?

Latest shareholding for JUBILANT INGREVIA LIMITED (JUBLINGREA) on Fincrux: Promoters 45.22% (Sep 2026), FIIs 6.93% (Sep 2026), DIIs 25.18% (Sep 2026), Government 0.02% (Sep 2026), Public 21.69% (Sep 2026).

Where can I find JUBILANT INGREVIA LIMITED (JUBLINGREA) financials?

JUBILANT INGREVIA LIMITED (JUBLINGREA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show JUBLINGREA balance sheet and cash flow?

Yes. The JUBILANT INGREVIA LIMITED (JUBLINGREA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:40


Designed & Shipped by Harshit Bansal